We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+44%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.33B
AUM Growth
+$540M
Cap. Flow
-$63.6M
Cap. Flow %
-2.73%
Top 10 Hldgs %
24.47%
Holding
282
New
21
Increased
69
Reduced
147
Closed
24

Top Buys

Rank Stock Value
1
LRN icon
Stride
LRN
+$26.5M
2
QLYS icon
Qualys
QLYS
+$16M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$7.48M
4
FN icon
Fabrinet
FN
+$6.66M
5
EEFT icon
Euronet Worldwide
EEFT
+$6.57M

Top Sells

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$31M
2
CMPR icon
Cimpress
CMPR
+$13.6M
3
WIX icon
WIX.com
WIX
+$13.4M
4
PLAY icon
Dave & Buster's
PLAY
+$10M
5
EBS icon
Emergent Biosolutions
EBS
+$7.66M

Sector Composition

Rank Sector Weight
1 Healthcare 24.77%
2 Technology 22.91%
3 Industrials 17.01%
4 Consumer Discretionary 13.19%
5 Communication Services 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EEFT icon
26
Euronet Worldwide
EEFT
$2.7B
$25.6M 1.1%
266,643
+71,178
+36% +$6.57M
RVNC
27
DELISTED
Revance Therapeutics, Inc.
RVNC
$25.2M 1.08%
1,033,279
+2,998
+0.3% +$59.2K
IAA
28
DELISTED
IAA, Inc. Common Stock
IAA
$25.1M 1.08%
649,716
+27,307
+4% +$1.02M
MTN icon
29
Vail Resorts
MTN
$5.3B
$24.9M 1.07%
136,906
-4,803
-3% -$840K
AX icon
30
Axos Financial
AX
$5.68B
$24.5M 1.05%
1,108,677
-32,014
-3% -$651K
ON icon
31
ON Semiconductor
ON
$31.6B
$22.2M 0.95%
1,118,930
-29,235
-3% -$476K
SUPN icon
32
Supernus Pharmaceuticals
SUPN
$2.77B
$22M 0.94%
925,486
-22,069
-2% -$488K
SSTK icon
33
Shutterstock
SSTK
$219M
$20.7M 0.89%
592,234
-85,341
-13% -$3.07M
WIFI
34
DELISTED
Boingo Wireless, Inc.
WIFI
$20.1M 0.86%
1,510,891
-41,468
-3% -$542K
RETA
35
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$19.9M 0.85%
127,638
+26,712
+26% +$4.06M
PBH icon
36
Prestige Consumer Healthcare
PBH
$2.6B
$19.8M 0.85%
527,572
-17,234
-3% -$689K
BSTC
37
DELISTED
BioSpecifics Technologies Corp.
BSTC
$19.2M 0.82%
312,725
-9,269
-3% -$536K
IOVA icon
38
Iovance Biotherapeutics
IOVA
$2.87B
$18.7M 0.8%
679,937
+227,595
+50% +$7.48M
AKBA icon
39
Akebia Therapeutics
AKBA
$252M
$18.6M 0.8%
1,372,888
-34,276
-2% -$355K
AERI
40
DELISTED
Aerie Pharmaceuticals
AERI
$18.6M 0.8%
1,256,918
-29,213
-2% -$432K
QLYS icon
41
Qualys
QLYS
$6.35B
$18.5M 0.79%
177,990
+152,298
+593% +$16M
AIMT
42
DELISTED
Aimmune Therapeutics
AIMT
$18.3M 0.78%
1,093,144
+110,660
+11% +$1.88M
OZK icon
43
Bank OZK
OZK
$5.61B
$17.6M 0.76%
750,664
-21,982
-3% -$471K
CSOD
44
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$17.5M 0.75%
454,141
-14,214
-3% -$500K
COLL icon
45
Collegium Pharmaceutical
COLL
$956M
$17.4M 0.75%
996,618
-37,203
-4% -$728K
ECHO
46
DELISTED
Echo Global Logistics, Inc.
ECHO
$17.2M 0.74%
793,930
-76,798
-9% -$1.44M
PGTI
47
DELISTED
PGT, Inc.
PGTI
$16M 0.69%
1,023,558
-131,063
-11% -$1.58M
GBT
48
DELISTED
Global Blood Therapeutics, Inc.
GBT
$15.1M 0.65%
239,607
+17,352
+8% +$1.19M
TFX icon
49
Teleflex
TFX
$5.98B
$14.9M 0.64%
40,812
-631
-2% -$218K
KPTI icon
50
Karyopharm Therapeutics
KPTI
$48M
$14.4M 0.62%
50,788
+11,005
+28% +$3.25M
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Rice Hall James & Associates held 282 positions worth $2.33B, up 30% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q2 2020 filing shows 21 new, 69 increased, 147 reduced and 24 closed positions. Its largest new stake was Fabrinet: 108,539 shares worth $6.78M. The largest sale was Trade Desk, an estimated $31M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q2 2020 buy was Fabrinet: 108,539 shares worth $6.78M.
  • Rice Hall James & Associates added most to Stride in Q2 2020, an estimated $26.5M increase.
  • Rice Hall James & Associates's biggest Q2 2020 reduction was Trade Desk, cutting an estimated $31M.
  • Rice Hall James & Associates fully exited Cimpress in Q2 2020, selling an estimated $13.6M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.33B portfolio in Q2 2020.
  • Rice Hall James & Associates opened 21 new positions and closed 24 in Q2 2020.
  • Rice Hall James & Associates's portfolio value rose 30% quarter-over-quarter to $2.33B.

Based on Rice Hall James & Associates's 13F filing for Q2 2020, filed 14 Aug 2020.